D-65 | Major adverse cardiovascular outcomes after percutaneous coronary intervention in patients treated with GLP-1 receptor agonists: A comparison of single- versus dual-incretin therapy

Authors

• Prabhjot Hundal, Advocate Health - MidwestFollow
• Ekow Essien, Advocate Health - MidwestFollow
• Abena Agyekum
• Suhail Q. Allaqaband, Advocate Health - MidwestFollow
• Tanvir K. Bajwa, Advocate Health - MidwestFollow
• M Fuad Jan, Advocate Health - MidwestFollow

Recommended Citation

Hundal P, Essien E, Agyekum A, Allaqaband SQ, Bajwa TK, Jan MF. D-65 | Major Adverse Cardiovascular Outcomes After Percutaneous Coronary Intervention in Patients Treated With GLP-1 Receptor Agonists: A Comparison of Single- Versus Dual-Incretin Therapy. Journal of the Society for Cardiovascular Angiography & Interventions. 2026;5(4, Supplement):104933. doi:https://doi.org/10.1016/j.jscai.2026.104933

Affiliations

Aurora Sinai/Aurora St. Luke's Medical Centers

Type

Abstract